precision neurology

A clinical-stage company developing novel, precisely targeted therapies for genetic neurodegenerative diseases

At ESCAPE, we’re passionate about helping people suffering from inherited forms of neurodegeneration. Our pipeline includes candidates targeting known genetic drivers of multiple diseases. Our goal is to improve the lives of patients suffering from Alzheimer's disease, Parkinson's disease, and CNS lysosomal storage disorders.

Diversified pipeline with
3 small molecules

MORE

ESB1609 (AN S1P5 SELECTIVE AGONIST) HAS COMPLETED A PHASE I MULTIPLE ASCENDING DOSE STUDY

MORE

LRRK2 KINASE INHIBITORS

MORE

An approach that increases the probability of success

Precision therapies targeting specific genetic populations have already come to market for other difficult-to-treat disease areas, such as cancer.

MORE